Blood ketone meters market seen rising on diabetes and home testing demand

The Business Research Company says the blood ketone meters market is set to grow from $0.44 billion in 2025 to $0.68 billion by 2030 as diabetes cases rise and home, connected monitoring tools gain traction. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Blood ketone meters are becoming more important for diabetes management, ketogenic diet users and people at risk of diabetic ketoacidosis. - The market outlook points to sustained demand for portable testing tools as remote monitoring and preventive care expand. - Rising diabetes prevalence is a key driver because blood ketone testing can help detect dangerous ketone buildup earlier.

What happened: - The Business Research Company released a report on the global blood ketone meters market on July 29, 2026. - The report projects the market will rise from $0.44 billion in 2025 to $0.48 billion in 2026. - The report expects the market to reach $0.68 billion by 2030. - The report forecasts a 9.2% CAGR for 2025-2026 and a 9.0% CAGR through 2030. - The report identifies North America as the largest market in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - Download a free sample of the market report. - View the full market report.

The details: - Blood ketone meters are portable devices that measure beta-hydroxybutyrate in the bloodstream. - The devices use a small drop of blood, often from a fingertip. - The meters are used to track ketosis levels. - The report links market growth to rising diabetes prevalence, wider ketogenic diet adoption, greater awareness of diabetic ketoacidosis, growth in point-of-care diagnostics and broader access to portable ketone meters. - The report also points to remote patient monitoring systems, connected diagnostic technologies, preventive diabetes care, digital health platforms and personalized metabolic monitoring as growth drivers through 2030. - The report highlights dual-analyte monitoring devices, home-based ketone testing, smartphone connectivity, continuous ketone monitoring and earlier DKA detection as major trends. - The International Diabetes Federation said in an April 2023 report that about 589 million adults were living with diabetes in 2024. - The International Diabetes Federation projected that number would climb to 853 million by 2050. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, hotspot infographics, and updated graphics and tables.

Between the lines: - The market is shifting from simple spot-check devices toward connected and continuous monitoring tools. - Home testing and smartphone-linked devices fit a broader move toward consumer-friendly chronic disease management. - The diabetes growth figures suggest the addressable market for ketone testing may keep widening even if adoption varies by region.

What's next: - The report expects more investment in digital health and personalized metabolic monitoring to support market growth. - Asia-Pacific could narrow the gap with North America as healthcare access and diagnostic adoption improve. - Device makers are likely to keep pushing connectivity and early-warning features as differentiation points.

The bottom line: - Blood ketone meters are moving from niche monitoring tools to a broader part of diabetes and home health workflows.